Status:
COMPLETED
Comparison of Two Empirical Antimicrobial Therapies of Prosthetic Joint Infection
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Bone and Joint Infection
Eligibility:
All Genders
18-100 years
Brief Summary
The empirical use of vancomycin in combination with a broad-spectrum beta-lactam is currently recommended after the initial surgery of prosthetic joint infection (PJI). However, the tolerability of su...
Detailed Description
The empirical use of vancomycin in combination with a broad-spectrum beta-lactam is currently recommended after the initial surgery of prosthetic joint infection (PJI). However, the tolerability of su...
Eligibility Criteria
Inclusion
- patients having had a prosthetic joint infection and having had a postoperative empirical antibiotherapy with combination of vancomycine and piperacillin-tazobactam or vancomycine and cefepime
Exclusion
- none
Key Trial Info
Start Date :
December 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT03850860
Start Date
December 1 2018
End Date
June 1 2019
Last Update
September 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon
Lyon, France, 69004